Adenocarcinoma D000230

Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Glandular and Epithelial » Carcinoma » Adenocarcinoma

Description

A malignant epithelial tumor with a glandular organization.   MeSH

Hierarchy View

Subtype Terms (29)

Adenocarcinoma, Clear Cell
21 drugs (15 approved, 6 experimental)

Adenocarcinoma, Follicular
1 approved drug

Adenocarcinoma in Situ
2 drugs (1 approved, 1 experimental)

Adenocarcinoma, Mucinous
10 drugs (9 approved, 1 experimental)

Adenocarcinoma of Lung
73 drugs (37 approved, 36 experimental)

Adenocarcinoma, Papillary
3 drugs (2 approved, 1 experimental)

Adenocarcinoma, Scirrhous
1 experimental drug

Adenocarcinoma, Sebaceous
 

Adrenocortical Carcinoma
48 drugs (30 approved, 18 experimental)

Carcinoid Tumor
43 drugs (29 approved, 14 experimental)

Carcinoma, Acinar Cell
4 drugs (2 approved, 2 experimental)

Carcinoma, Adenoid Cystic
59 drugs (36 approved, 23 experimental)

Carcinoma, Ductal
9 drugs (7 approved, 2 experimental)

Carcinoma, Endometrioid
15 drugs (9 approved, 6 experimental)

Carcinoma, Hepatocellular
570 drugs (186 approved, 384 experimental)

Carcinoma, Intraductal, Noninfiltrating
29 drugs (25 approved, 4 experimental)

Carcinoma, Islet Cell
28 drugs (22 approved, 6 experimental)

Carcinoma, Lobular
3 approved drugs

Carcinoma, Mucoepidermoid
37 drugs (25 approved, 12 experimental)

Carcinoma, Neuroendocrine
47 drugs (32 approved, 15 experimental)

Carcinoma, Renal Cell
493 drugs (162 approved, 331 experimental)

Carcinoma, Signet Ring Cell
2 approved drugs

Carcinoma, Skin Appendage
 

Cholangiocarcinoma
201 drugs (92 approved, 109 experimental)

Choriocarcinoma
29 drugs (25 approved, 4 experimental)

Cystadenocarcinoma
 

Eccrine Porocarcinoma
 

Paget Disease, Extramammary
10 approved drugs

Pulmonary Adenomatosis, Ovine
 


Approved Indicated Drugs (1)

Phase 2 Indicated Drugs (94)


Organization Involved with Phase 3 Indications (200)

Deutsche Krebshilfe e.V.

Dutch Colorectal Cancer Group

Eastern Cooperative Oncology Group

ECOG-ACRIN Cancer Research Group

Egyptian Foundation for Cancer Research

Eisai

Eleison Pharmaceuticals

Eli Lilly

Endo Pharmaceuticals

ERYtech Pharma

Eurofarma Laboratorios S.A.

European Organisation for Research and Treatment of Cancer

Federation Francophone de Cancerologie Digestive

Fudan University

Fujian Medical University

Fundación Althaia Manresa

Genentech

Geneplus-Beijing Co. Ltd.

German Research Foundation

Gilead Sciences

GlaxoSmithKline

Government of Canada

Greater Washington Community Foundation

Groupe Francais De Pneumo-Cancerologie

Groupe Hospitalier Paris Saint Joseph

Grupo de Investigación Clínica en Oncología Radioterapia

Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente

Gruppo Oncologico Chirurgico Cooperativo Italiano

Gruppo Oncologico del Nord-Ovest

Gruppo Oncologico Italiano di Ricerca Clinica

Gynecologic Oncology Group

Halozyme Therapeutics

Harvard University

Henan Medical University

Hengrui Therapeutics, Inc.

Hospital general Universitario de Ciudad Real

Hospital Universitario Lucus Augusti

Huazhong University of Science and Technology

IKF Klinische Krebsforschung GmbH am Krankenhaus Nordwest

Innovent Biologics (Suzhou) Co. Ltd.

Institut Bergonié

Institut de Cancérologie de Lorraine

Institut de Cancerologie de l'Ouest Paul Papin

Institut Gustave Roussy

Instituto do Cancer do Estado de São Paulo

Institut Paoli-Calmettes

Institut Sainte Catherine

Ipsen

IQVIA

Istituto Nazionale per lo Studio e la Cura dei Tumori

Organization Involved with Phase 2 Indications (435)

AbbVie

Academic GI Cancer Consortium

Aduro BioTech

Advaxis, Inc.

AIDS Malignancy Consortium

Aix-University of Marseille

Ajou University

Akeso Pharmaceuticals, Inc.

Alcedis GmbH

Allergan

American Association for Cancer Research

American University of Beirut

Anchiano Therapeutics

Anyang Regional Hospital

Apexigen, Inc.

Apices Soluciones S.L.

Aptium Oncology

Aqualis

Arbeitsgemeinschaft medikamentoese Tumortherapie

Ariad Pharmaceuticals

ArQule

Array BioPharma

Arrys Therapeutics

Ascentage Pharma Group Inc.

Asociación de Oncología Médica del Hospital de Cruces

Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials

Astex Pharmaceuticals, Inc.

AVAX Technologies

Axcentua Pharmaceuticals AB

Axelar AB

Bankhead-Coley Florida Biomedical Research Program

Baptist Health

Barretos Cancer Hospital

Barts & The London NHS Trust

Basilea Pharmaceutica

Bausch Health Companies

Bavarian Nordic

Baxalta

Bayer

BerGenBio ASA

Big Ten Cancer Research Consortium

Biocompatibles International plc

Biogen

BioLineRx, Ltd.

Blood Transfusion Centre of Slovenia

Blue Earth Diagnostics

Boston University

Bracco

British Columbia Cancer Agency

Brown University

BTG

Burzynski Research Institute

Canadian Cancer Society

Cancer Research Institute

Cancer Treatment Centers of America

Candel Therapeutics

Cantargia AB

CARsgen Therapeutics, Ltd.

Cascadian Therapeutics Inc.

Case Western Reserve University

Catalysis SL

Cato Research

Cedars-Sinai Medical Center

Centre for Probe Development and Commercialization

Centre Georges Francois Leclerc

Centre Hospitalier La Source, Orleans

Centre Jean Bernard

Chang Gung University

Changhai Hospital

Changhua Christian Hospital

Chao Family Comprehensive Cancer Center

Chengdu Kanghong Biotech Co.,Ltd.

Chimei Medical Center

China Medical University

ChiRhoClin, Inc.

Chiron

Chonnam National University

CHR Annecy

CHU Besançon

CHU Henri Mondor

CHU Morvan

Chungnam National University

City of Hope National Medical Center

City University of New York

ClinAssess GmbH

Clovis Oncology

CM&D Pharma

CMX Research

CNAO National Center of Oncological Hadrontherapy

Cold Spring Harbor Laboratory

Columbia University

Criterium, Inc.

Cure&Sure Biotech Co., LTD

Cyclopharma

CytRx

Daiichi

Daiichi Sankyo

Dalian Medical University

Department of Defense

Destroy Pancreatic Cancer

Duke University

E-Group ICT Software Informatikai Zrt.

Emory University

Endocyte

Essentia Health

Europejskie Centrum Zdrowia Otwock

Exelixis

Ferring

First People's Hospital of Hangzhou

First People's Hospital of Shangqiu

Fondazione del Piemonte per l'Oncologia

Fondazione GISCAD

Fortress Biotech

Foundation IRCCS San Matteo Hospital

Foundation Medicine

Free University of Brussels

Fundación de investigación HM

Ganymed Pharmaceuticals AG

Gateway for Cancer Research

GCP-Service International Ltd. & Co. KG

General Oncology, Inc.

Genta

Genzyme

George Mason University

Georgetown University

Ghent University

GMP BIO Co., LTD.

Gossamer Bio Inc.

Government of Brazil

Government of Taiwan

Gritstone Oncology, Inc.

Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)

Grupo Espanol Multidisciplinario del Cancer Digestivo

Grupo Gallego de Investigaciones Oncologicas

Grupo Hospital de Madrid

Guangdong Province Association Study of Thoracic Oncology

Guangzhou Medical University

Gundersen Health System

GWT-TUD GmbH

Hamilton Health Sciences Corporation

Hanmi Pharmaceutical

Harbin Medical University

Helix BioPharma Corporation

Hellenic Cooperative Oncology Group

Hemispherx Biopharma

Herbert Irving Comprehensive Cancer Center

HonorHealth Research Institute

Hoosier Cancer Research Network

Hôpital Saint Antoine - PARIS

Hospital A.C. Camargo

Hospital Avicenne

Hospital Universitario Carlos Haya

Hospital Universitario de Fuenlabrada

Hospital Universitario Santander

Humboldt University

IASON Gmbh

Icahn School of Medicine at Mount Sinai

Imaging Endpoints

Imclone

Immunex

Immunicum AB

ImmunogenX

Immunomedics

Immutep S.A.

Imperial College London

Imugene Limited

Incyte

Indiana University

Innate Pharma

Institute for Developmental Cancer Therapeutics

Institut Mutualiste Montsouris

Intergroupe Francophone de Cancerologie Thoracique

International Group of Endovascular Oncology

InvivoGen

Ioannina University Hospital

Iovance

Istituto di Candiolo

James and Esther King Biomedical Research Program

Jazz Pharmaceuticals

Jiaozuo Tumor Hospital

Johannes Gutenburg University

Kaohsiung Medical University

KCR S.A.

King Faisal Specialist Hospital

King Faisal University

Kliniken Nordoberpfalz AG Klinikum Weiden Medizinische Kliniken I

Klus Pharma Inc.

Konkuk University

Korean Association for the Study of Targeted Therapy

Korea University

Kosin University

Kunming Medical University

Kyungpook University

Laboratorio Elea S.A.C.I.F. y A.

Leap Therapeutics, Inc.

Lexicon Pharmaceuticals

Lokon Pharma AB

Loma Linda University

Lousiana Health Sciences Center - Shreveport

Lund University

LungenClinic Grosshansdorf

Lustgarten Foundation

Mackay Medical College

Marche Polytechnic University

Maryland Cigarette Restitution Fund

McGill University

McMaster University

Mebiopharm Co., Ltd

Medical College of Wisconsin

MedicalLogic

Medical University of Vienna

MediGene

MedImmune

MedPacto, Inc.

Memorial Cancer Institute, Florida

Memorial Sloan-Kettering Cancer Center

Mercy Medical Center

Mereo BioPharma

Merrimack Pharmaceuticals

Miguel Hernández University

Milad Hospital

Millennium Pharmaceuticals

Morphotek

Mucpharm Pty Ltd

Nanobiotix

NanOlogy, LLC

NantWorks

Nanyang Central Hospital

Nanyang Medical College

National Comprehensive Cancer Network

Nationales Centrum fur Tumorerkrankungen

National Institutes of Health (NIH)

National Natural Science Foundation of China

National OncoVenture

National Taiwan University

National University of Singapore

Nebraska Cancer Specialists

NeoImmuneTech, Inc.

Neovii Biotech

Netherlands Cancer Institute

NewLink Genetics Inc

New Mexico Cancer Care Alliance

Noordwest Ziekenhuisgroep

Nordic Pharma Group

North Eastern Germany Society of Gynaecologic Oncology

Northeast Ohio Medical University

Northwell Health

Northwestern University

Norwegian University of Science and Technology

Novartis

Oddzial Chemioterapii Krakow

Oddzial Kliniczny Kliniki Onkologii

Oddzial Onkologii Klinicznej im L Rydygiera

Ohio State University

OHSU Knight Cancer Institute

OncoGenex Technologies

Oncolys BioPharma Inc

Oncolytics Biotech

Ontario Institute for Cancer Research

Onyvax

Orca Therapeutics B.V.

Oregon Health and Science University

Osakidetza

OSE Immunotherapeutics

OSI Pharmaceuticals

Pancreatic Cancer Canada

Pancreatic Cancer Research Team

Parirenyatwa Hospital

Pennsylvania State University

Pharmacia & Upjohn

PharmaEngine

Philipps University of Marburg

Phoenix Biotechnology, Inc

Phoenix Clinical Research Center

Phoenix Molecular Imaging

Piedmont Hospital

Point Therapeutics

PPD

Princeton University

Prism Research

Providence Health & Services

Pusan National University

Puyang Oil Field General Hospital

Queensland University of Technology

Radboud University

Radiation Oncology Center of Olathe

Ramón González Coro Hospital

Rampart Health, L.L.C.

Regeneron

Regionalny Szpital Specjalistyczny Latawiec

Rhode Island Hospital

Rongjie Tao

Rouen Normandy University

Rutgers University

Sabinsa Corporation

Salk Institute for Biological Studies

Samyang Biopharmaceuticals Corporation

Sanofi

Sanofi-Synthelabo

Scandion Oncology A/S

SCRI Development Innovations

Scripps

Shandong University

Shanghai Junshi Bioscience Co.,Ltd.

Shanxi Medical University

Shengjing Hospital

Shenma Medical Group General Hospital

Shire

Silenseed Ltd

Simcere Pharmaceutical Co., Ltd

Situs Cancer Research Center

Sky Foundation

Soonchunhyang University

Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

Spanish Lung Cancer Group

Spectrum Pharmaceuticals

Stand Up To Cancer

State University of New York, Buffalo

St. Luke's-Roosevelt Hospital Center

Suzhou Sheng Diya Biomedical Co., Ltd.

Swedish Cancer Institute

Syndax Pharmaceuticals

Syntax for Science

Taichung Veterans General Hospital

Taipei Veteran General hospital

Tangshan People's Hospital

Tarveda Therapeutics

Technical University of Munich

Technion University

Tel Aviv University

Telix

Temple University

Tesaro

TetraLogic Pharmaceuticals

TGen Drug Development

The First People's Hospital of Changzhou

The National Cancer Center

The Parker Institute

TheraOp

ThermaSolutions Inc.

The University of Hong Kong

The University of Texas, Dallas

The Wayne D. Kuni and Joan E. Kuni Foundation

Thomas Jefferson University

Tianjin Medical University

Tracon Pharmaceuticals Inc.

Translational Oncology Research International

Trial Form Support S.L.

Trinity College Dublin

TTY Biopharm

Universidad Carlos III Madrid

University Hospital Hradec Kralove

University of Alabama, Birmingham

University of Alberta

University of Angers

University of Arizona

University of Bern

University of Birmingham

University of Bordeaux

University of Caen-Normandie

University of Calgary

University of California, Davis

University of California, Irvine

University of California, San Diego

University of Campinas

University of Cantabria

University of Cincinnati

University of Cologne

University of Colorado

University of Colorado, Denver

University of Florida

University of Franche-Comté

University of Geneva

University of Glasgow

University of Groningen

University of Hamburg

University of Heidelberg

University of Iowa

University of Kansas

University of Leipzig

University of Lille

University of Louisville

University of Maryland

University of Medicine and Dentistry of New Jersey

University of Michigan

University of Minnesota

University of Montreal

University of Nebraska

University of New Mexico

University of New South Wales

University of North Carolina at Chapel Hill

University of Oklahoma

University of Pecs

University of Pittsburgh

University of Queensland

University of Rochester

University of Saskatchewan

University of South Carolina

University of South Florida

University of Texas, Galveston

University of Texas, San Antonio

University of Toronto

University of Tuebingen

University of Ulm

University of Ulsan

University of Utah

University of Verona

University of Virginia

University of Washington

University of Western Ontario

University of Wisconsin

US Biotest

US Oncology

Utrecht University

ValiRx

Vanderbilt University

Vasgene Therapeutics, Inc

Vedanta Biosciences, Inc.

Verastem, Inc.

Virginia Commonwealth University

Virginia Mason Medical Center

Virginia Polytechnic Institute and State University

Vivus

Wakayama Medical University

Wake Forest University

Washington University in St. Louis

Welichem Biotech Inc.

Wenzhou Medical University

Xiamen University

Xinyang Central Hospital

Yale University

Yeshiva University

Zeria Pharmaceutical

Zhejiang University

Zymeworks Inc.

Organization Involved with Phase 1 Indications (93)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.